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Summary Data from the Thames Cancer Registry were compared with data independently abstracted from
medical records for 466 patients with confirmed cancer of the bladder diagnosed in 1982. High levels of
agreement were observed for five continuous variables and for tumour morphology. Data concerning tumour
stage did not clearly distinguish superficial from invasive tumours. Cancer registry data were found to be
reliable except for tumour stage which may not be clearly documented in clinical records.
England is one of a small number of countries with a
national system of population based cancer registries (Water-
house et al., 1982). The data collected are published at
national level (Office of Population Censuses and Surveys,
1985) and provide information concerning the incidence and
duration of survival with cancer (Cancer Research Cam-
paign, 1982). Cancer registry data also have uses in
epidemiological research and health service planning (Office
of Population Censuses and Surveys, 1990), their value as a
starting point for auditing the effectiveness of cancer treat-
ment has also been emphasised (Gillis et al., 1991). As cancer
registry data may be put to a number of practical uses it is
important to evaluate their quality. The completeness with
which cases are ascertained by registries has been investigated
in several studies (Nwene & Smith, 1982). The reliability of
cancer registry data has not often been studied. We com-
pared data obtained from the Thames Cancer Registry with
data independently abstracted from the same patients'
medical records.
Methods
The reliability of cancer registry records was investigated by
comparing Thames Cancer Registry data with data obtained
from hospital case notes and radiotherapy records for all
men resident in the South East and South West Thames
Regions, who were aged less than 75 years at diagnosis and
who had bladder cancer first diagnosed in 1982. These cases
were identified from the Thames Cancer Registry records
and, after permission had been obtained from clinicians,
hospital notes and radiotherapy records were examined at the
hospitals where they were treated. Data were abstracted by
one medically qualified investigator using standard data col-
lection forms in 1989 and 1990. The cases in the two data
sets were matched using the Thames Cancer Registry number
which uniquely identifies each record held at the cancer
registry. For the present analysis, data obtained from the
cancer registry are referred to as 'original' and those from
hospital case notes as 'review'.
Comparisons were made for ten items of data. These were:
date of birth; date of diagnosis; date of death; date of first
operation; date of first radiotherapy treatment; histological
type; extent of tumour invasion; receipt of radiotherapy and
dose of radiation administered; use of chemotherapy. The
histological type of tumour was coded at the Thames Cancer
Registry using the codes of the International Classification of
Diseases for Oncology (World Health Organisation, 1976).
The histological type was coded from hospital notes into the
categories: transitional cell; squamous cell; anaplastic; car-
cinoma in situ; other (specify); not known. The extent of
tumour invasion was coded at Thames Cancer Registry ac-
cording to whether or not the primary tumour showed
evidence of local extension beyond the organ of origin, and
whether there was nodal involvement (yes/no) and metastases
(yes/no). Clinical evidence was accepted if there was no
pathological evidence. When data were abstracted from hos-
pital records the histological extent of tumour invasion was
classified into the categories 'mucosal', 'submucosal', muscle
invasion', 'extravesical spread', 'lymph node involvement',
'metastasis' and 'not known'. For analysis these cateogries
were reduced to the levels' 'mucosal' (pTa); 'submucosal
invasion' (pTl); 'muscle invasive' (>pT2); 'not known'.
Agreement between continuous variables (including dates)
was estimated by calculating the difference between the
values recorded at the cancer registry and from hospital
records. As the level of agreement was high, the data were
presented as the number (and proportion as a percentage) of
cases showing exact agreement and the distribution of values
for cases not showing exact agreement. The degree of agree-
ment between categorical variables was estimated by cal-
culating the kappa stastic and 95% confidence intervals
(Fleiuss, 1981). The kappa statistic provides a measure of
agreement, corrected for the level of agreement expected by
chance. Values greater than 0.75 indicate excellent agreement,
0.40 to 0.75 fair to good agreement, and values less than 0.40
poor agreement.
Results
The selection of cases has been reported previously (Gulliford
et al., 1991a; Gulliford et al., 1991b). The Thames Cancer
Registry supplied a list of 609 cases with bladder cancer
believed to fulfill the entry criteria for the study. For 12 (2%)
cases registration was from death certificate only. In 96 cases
(16%) neither hospital notes nor radiotherapy records could
be retrieved because they were lost or destroyed or the
clinician (one surgeon and one radiotherapist) refused access
to records. Four patients (0.7%) were found not to have
been resident in the South Thames Regions at the time of
diagnosis. In seven cases (1%), review of the notes showed
that an initial clinical diagnosis of bladder cancer had not
been confirmed by subsequent investigation. In a further two
cases the biopsy result was normal but the patients were
managed clinically as cases of bladder cancer. On review, the
year of diagnosis was found not to be 1982 in 24 cases (4%).
Further analysis was confined to 466 (77%) cases who were
resident in the South Thames regions with a confirmed diag-
nosis of bladder cancer made in 1982, for whom notes were
retrieved for review.
Table I shows agreement for five continuous variables
compared for the two sources of data. There was exact
agreement for a high proporiton of cases and for discordant
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Table I Agreement between cancer registry data and data obtained from
hospital case notes for continuous variables
Variable No exact agreement
(cases with Exact agreement number (%) median
complete data) number (%) (interquartile range)
Date of birth (464) 432 (93) 32 (7) 0 (-32 to 31 days)
Date of death (218) 202 (93) 16 (7) 1 (-3 to 5) days
Date of first 311 (83) 65 (17) -1 (-10 to 3) days
operation (376)
Date of first 138 (88) 18 (12) -2 (-18 to 1) days
radiotherapy (156)
Dose of 123 (84) 23 (16) 14 (1 to 20) Gray
radiotherapy (146)
cases differences were generally of small magnitude. Because
the cases were selected according to confirmed date of diag-
nosis, a valid comparison could not be made for this
variable. However, of the 466 cases, date of diagnosis was
avialable in both data sets for 430, exact agreement was
present in 307 (71%) cases, for discordant cases the median
difference was - 1 day (interquartile range - 4 to 7 days).
The level of agreement for classification of histological cell
type was also good. 402 cases were recorded as transitional
cell carcinoma in the review data and 355 (88%) of these
were recorded as transitional cell carcinoma or papillary
transitional cell carcinoma in the original data (Table II).
High levels of concordance were observed for the smaller
numbers of cases in the other categories.
Table III shows the staging information originally recorded
at the cancer registry compared with pathological T-stage
obtained by reviewing hospital notes: 187 out of 242 (77%)
cases recorded as non-invasive (pTa) or micro-invasive (pTl)
were recorded as 'local' at the cancer registry. However, 45
out of 93 (48%) of tumours classified as invasive (>pT2)
were classified as 'local' in the cancer registry data. Thus the
categories 'local' and 'local extension' did not adequately
distinguish between superficial and invasive bladder tumours.
There were 131 (28%) of case notes which gave no patho-
logical indication of tumour stage at review and 74 (16%) for
which descriptive information had been missing at registra-
tion.
Of 203 cases receiving radiotherapy, 88% were recorded as
such at the cancer registry (kappa 0.88 (0.79-0.97)). Of 85
Table II Histological classification
Hospital records
Transitional cell
ca (TCC)
N = 402
Squamous cell ca
(SCC) N= 7
Anaplastic ca
N = 7
Carcinoma in situ
(CIS)
N = 6
Normal biopsy
N = 2
Adenocarcinoma (3)
Spindle cell ca (1)
Malignant fibrous histiocytoma (1)
Other uncertain (1)
cases receiving chemotherapy, 15% were recorded as such at
the registry (kappa 0.41 (0.32-0.49)).
Discussion
The Thames Cancer Registry employs specially trained peri-
patetic clerks to complete cancer registration forms. This
report suggests that the data abstracted by these clerks
generally showed a high level of agreement with data
independently abstracted from hospital records for another
study. This finding confirms observations on the reliability of
abstraction of data made in the United States (Horwitz &
Yu, 1984). In particular it was reassuring that the dates of
initial treatment and death, which may be used in analysis of
patient survival, appeared to be reliably recorded in the
cancer registry records for the majority of cases.
The selection of cases for this study was not unbiased
(Gulliford et al., 1991a). In addition to a high proportion of
cases for whom case notes could not be retrieved, a number
of cases were excluded. These included seven cases in whom
a diagnosis of bladder cancer had not been confirmed.
Usually an initial clinical diagnosis of bladder cancer had not
been supported by subsequent investigation, either because
the tumour was found to originate in another organ or
because a non-neoplastic pathology was identified. In 24
cases the date of diagnosis was found not to have been 1982.
In most of these cases a diagnosis of superficial bladder
cancer (papilloma) had been made a number of years
of tumour ascertained from hospital records and from the
cancer registry
Cancer registry (ICD-O code)
M81203 TCC NOS
M81303 papillary TCC
M80103 carcinoma NOS
M80503 papillary carcinoma NOS
Eight other codes
M80703 SCC NOS
M80713 SCC Keratinising type
M80103 carcinoma NOS
M81203 TCC NOS
M81403 Adenocarcinomas
M80102 CIS NOS
M81202 TCC in situ
M81303 papillary TCC
M80001 neoplasm, NOS
M81201 urothelial papilloma
M81403 adenocarcinoma NOS
M80323 spindle cell carcinoma
M80323 spindle cell carcinoma
M82513 alveolar adenocarcima
246
13
109
18
16
6
1
5
1
1
4
13
1
1
Not known (N = 36)
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Table III Comparison of measures of tumour invasion recorded from hospital
records and cancer registry data. (Figures are frequencies (percentage of row
total))
Hospital records Thames Cancer Registry (Original)
(Review) Nodal or
pT Number of Local distant Not
category patients Local extension metastases known
pTa 154 119 (77) 8 (5) 3 (2) 24
pTI 88 68 (77) 10 (11) 0 (0) 10
. pT2 93 45 (48) 20 (22) 6 (6) 22
Not known 131 97 10 6 18
Total 466 329 48 15 74
previously, at a time when the rules for registration of these
neoplasms by the registry were different. These cases were
not analysed further but their exclusion meant that the
reliability of date of diagnosis could not be fully evaluated.
This study was confined to tumours at a single site so it
was not possible to analyse the reliability of recording of
topographic information but it is relevant to note that for
one per cent of the original sample, a diagnosis of bladder
cancer was not confirmed on review. The original coding of
tumour morphology was consistent with that independently
obtained by reviewing clinical records.
It was clear that the recording of tumour stage presented
particular problems. In each data set there was a high pro-
portion of clinical records from which the tumour stage
could not be clearly identified. The relatively high proportion
of hospital records which did not include mention of the
clinical stage has also been noted in an American study
(Fiegl et al., 1988). In our study we found that the categories
of the TNM classification were rarely explicitly mentioned
either in clinical records or pathology reports, although the
latter often included a written statement of the information
required for classification (unpublished observations). The
poor quality of staging information contained in clinical
records was one of the reasons why the cancer registry
introduced a simplified staging system in 1981. However, the
categories of this simplified system did not allow separation
of superficial from invasive bladder tumours. Thus the re-
cording of staging information by clinicians and pathologists
needs to be improved before their records can be used as a
reliable source of information concerning tumour stage.
The cancer registry aims to collect data concerning initial
treatment within the first 6 months after diagnosis. The
present results show that this approach results in an incom-
plete record of the use of these treatment modalities when
compared with clinical records examined a number of years
later.
Cancer registry data showed good agreement with inform-
ation independently abstracted from patients' clinical records.
Recording of staging information in the clinical setting
appeared to be unsatisfactory because of the high proportion
of cases for which tumour stage was not mentioned and the
infrequent explicit use of the TNM classification. The quality
of staging data available to registries needs to be improved.
Increasing involvement ofclinicians and pathologists in regis-
tration might provide one method of achieving this.
We thank the clinicians who allowed us to examine their patients'
notes and Professor W.W. Holland for his support. The authors
were supported by the Wellcome Trust and the Department of
Health.
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